Alessandri C, Bartosiewicz I, Pendolino M, Mancini R, Colasanti T, Pecani A, Morello F, Mastrangelo A, Sabatinelli D, Riccieri V, Di Franco M, Ceccarelli F, Perricone C, Conti F, Valesini G
Dipartimento di Medicina Interna e Specialità Mediche, Sapienza Università di Roma, Italy.
Clin Exp Rheumatol. 2015 Nov-Dec;33(6):824-30. Epub 2015 Sep 28.
To investigate the prevalence of anti-carbamylated protein antibodies (anti-CarP) in the healthy first-degree relatives (HFDRs) of patients with rheumatoid arthritis (RA).
We enrolled 141 HFDRs of 63 patients with RA diagnosed accordingly to the 2010 ACR/EULAR criteria. Fifty-six normal healthy subjects (NHS), sex- and age-matched, served as controls. Anti-CarP IgG, anti-cyclic citrullinated peptide antibody (anti-CCP) IgG and rheumatoid factors (RF) isotypes (IgG, IgA, IgM) were assessed by solid-phase ELISA.
Anti-CarP were detectable in 13 HFDRs (9.2%), anti-CCP in 9 (6.3%), IgG-RF in 10 (7%), IgA-RF in 17 (12%), and IgM-RF in 13 (9.2%) HFDRs. Twenty-nine (46%) RA patients were positive for anti-CarP, 31 (49.2%) for anti-CCP, and 34 (53.9%) for RF. One NHS (1.7%) resulted positive for anti-CarP, none for anti-CCP and RF. Anti-CarP showed significantly higher serum levels in RA and HFDRs than in NHS (p<0.0001 and p=0.0012, respectively). A significant correlation between anti-CCP and RF were found among RA patients (p=0.0002), whereas no correlations were reported between autoantibodies tested in the HFDRs.
Anti-CarP can be found in the sera of HFDRs of RA patients and their prevalence is significantly higher than in NHS. No correlation of anti-CarP with anti-CCP and RF antibodies in RA HFDRs was found.
调查类风湿关节炎(RA)患者的健康一级亲属(HFDRs)中抗氨甲酰化蛋白抗体(抗CarP)的患病率。
我们纳入了63例根据2010年美国风湿病学会(ACR)/欧洲抗风湿病联盟(EULAR)标准确诊的RA患者的141名HFDRs。56名年龄和性别匹配的正常健康受试者(NHS)作为对照。通过固相酶联免疫吸附测定法评估抗CarP IgG、抗环瓜氨酸肽抗体(抗CCP)IgG和类风湿因子(RF)各亚型(IgG、IgA、IgM)。
在13名HFDRs(9.2%)中可检测到抗CarP,9名(6.3%)中可检测到抗CCP,10名(7%)中可检测到IgG-RF,17名(12%)中可检测到IgA-RF,13名(9.2%)中可检测到IgM-RF。29名(46%)RA患者抗CarP呈阳性,31名(49.2%)抗CCP呈阳性,34名(53.9%)RF呈阳性。1名NHS(1.7%)抗CarP呈阳性,抗CCP和RF均为阴性。RA患者和HFDRs中抗CarP的血清水平显著高于NHS(分别为p<0.0001和p=0.0012)。在RA患者中发现抗CCP与RF之间存在显著相关性(p=0.0002),而在HFDRs中检测的自身抗体之间未报告相关性。
在RA患者的HFDRs血清中可发现抗CarP,其患病率显著高于NHS。未发现RA HFDRs中抗CarP与抗CCP和RF抗体之间存在相关性。